Potential future agents in the management of mCRPC

A new article by Antonarakis and Armstrong in full text on the Medscape web site reviews available information on a wide range of currently investigational agents for the treatment of metastatic, castration-resistant prostate cancer (mCRPC), including

Follow

Get every new post delivered to your Inbox.

Join 269 other followers